BioStem Technologies, Inc.
BSEM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1,708.9% | 142.7% | 58.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 95.4% | 92.4% | 87.2% | 66% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 10.4% | -45.3% | -94.8% | -13.9% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 10.6% | -50.8% | -102.9% | -33.3% |
| EPS Diluted | 1.47 | -0.62 | -0.62 | -0.12 |
| % Growth | 337.1% | 0% | -416.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |